Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Moore, DF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 98 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kang, DJ; Speaks, R; Peng, NH; Webb, R; Jeynes, C; Booij, WE; Tarte, EJ; Moore, DF; Blamire, MG
      Nanometer scale masked ion damage barriers in YBa2Cu3O7-delta

      IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY
    2. Moore, DF; Herscovitch, P; Schiffmann, R
      Selective arterial distribution of cerebral hyperperfusion in Fabry disease

      JOURNAL OF NEUROIMAGING
    3. Moore, DF; Chatterjee, N; Pee, D; Gail, MH
      Pseudo-likelihood estimates of the cumulative risk of an autosomal dominant disease from a kin-cohort study

      GENETIC EPIDEMIOLOGY
    4. Kelly, K; Crowley, J; Bunn, PA; Presant, CA; Grevstad, PK; Mainpour, CM; Ramsey, SD; Wozniak, AJ; Weiss, GR; Moore, DF; Israel, VK; Livingston, RB; Gandara, DR
      Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-celllung cancer: A Southwest Oncology Group trial

      JOURNAL OF CLINICAL ONCOLOGY
    5. Brady, RO; Murray, GJ; Moore, DF; Schiffmann, R
      Enzyme replacement therapy in Fabry disease

      JOURNAL OF INHERITED METABOLIC DISEASE
    6. Schiffmann, R; Kopp, JB; Austin, HA; Sabnis, S; Moore, DF; Weibel, T; Balow, JE; Brady, RO
      Enzyme replacement therapy in Fabry disease - A randomized controlled trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    7. Altarescu, G; Moore, DF; Pursley, R; Campia, U; Goldstein, S; Bryant, M; Panza, JA; Schiffmann, R
      Enhanced endothelium-dependent vasodilation in Fabry disease

      STROKE
    8. Schiffmann, R; Bonavita, S; Schiffmann, R; Moore, DF; Freir, K; Choir, B; Patronas, N; Virta, A; Buespflug-Tanguy, O; Tedeschi, G
      Evidence for neuroaxonal injury in patients with proteolipid gene mutations - Reply

      NEUROLOGY
    9. Bonavita, S; Schiffmann, R; Moore, DF; Frei, K; Choi, B; Patronas, N; Virta, A; Boespflug-Tanguy, O; Tedeschi, G
      Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations

      NEUROLOGY
    10. Altarescu, G; Hill, S; Wiggs, E; Jeffries, N; Kreps, C; Parker , CC; Brady, RO; Barton, NW; Schiffmann, R; Bannarjee, TK; Crutchfield, K; Frei, K; McKee, MA; Moore, DF; Tournay, A
      The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease

      JOURNAL OF PEDIATRICS
    11. Moore, DF; Scott, LTC; Gladwin, MT; Altarescu, G; Kaneski, C; Suzuki, K; Pease-Fye, M; Ferri, R; Brady, RO; Herscovitch, P; Schiffmann, R
      Regional cerebral hyperperfusion and nitric oxide pathway dysregulation inFabry disease - Reversal by enzyme replacement therapy

      CIRCULATION
    12. Moore, DF; Park, CK; Smith, W
      Exploring extra-binomial variation in teratology data using continuous mixtures

      BIOMETRICS
    13. Altarescu, G; Schiffmann, R; Parker, CC; Moore, DF; Kreps, C; Brady, RO; Barton, NW
      Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease

      BLOOD CELLS MOLECULES AND DISEASES
    14. Taylor, CW; LeBlanc, M; Fisher, RI; Moore, DF; Roach, RW; Elias, L; Miller, TP
      Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group Trial

      ANTI-CANCER DRUGS
    15. Moore, DF; Tsenova, L; Corral, L; Freedman, VH; Kaplan, G
      HUMAN alpha-1-acid glycoprotein inhibits TNF production in the CNS of rabbits with meningitis: A report of preliminary observations

      INFLAMMATION
    16. Macdonald, JS; Jacobson, JL; Modiano, M; Moore, DF; Gandara, DR; Schroder, LE; Chapman, RA
      A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) plus G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413)

      INVESTIGATIONAL NEW DRUGS
    17. Chauncey, TR; Rankin, C; Anderson, JE; Chen, IM; Kopecky, KJ; Godwin, JE; Kalaycio, ME; Moore, DF; Shurafa, MS; Petersdorf, SH; Kraut, EH; Leith, CP; Head, DR; Luthardt, FW; Willman, CL; Appelbaum, FR
      A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617

      LEUKEMIA RESEARCH
    18. Hesketh, PJ; Crowley, JJ; Burris, HA; Williamson, SK; Balcerzak, SP; Peereboom, D; Goodwin, JW; Gross, HM; Moore, DF; Livingston, RB; Gandara, DR
      Evaluation of docetaxel in previously untreated extensive-stage small celllung cancer: A Southwest Oncology Group phase II trial

      CANCER JOURNAL FROM SCIENTIFIC AMERICAN
    19. Booij, WE; Elwell, CA; Tarte, EJ; McBrien, PF; Kahlmann, F; Moore, DF; Blamire, MG; Peng, NH; Jeynes, C
      Electrical properties of electron and ion beam irradiated YBa2Cu3O7-delta

      IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY
    20. Moore, DF; Syms, RRA
      Recent developments in micromachined silicon

      ELECTRONICS & COMMUNICATION ENGINEERING JOURNAL
    21. Moore, DF; Milne, WI; Oda, S
      Nanostructured materials and devices for sensor and electronic applications

      POWER ENGINEERING JOURNAL
    22. Daniel, JH; Moore, DF
      A microaccelerometer structure fabricated in silicon-on-insulator using a focused ion beam process

      SENSORS AND ACTUATORS A-PHYSICAL
    23. Ulug, AM; Moore, DF; Bojko, AS; Zimmerman, RD
      Clinical use of diffusion-tenser imaging for diseases causing neuronal andaxonal damage

      AMERICAN JOURNAL OF NEURORADIOLOGY
    24. Moore, DF; Brown, TD; LeBlanc, M; Dahlberg, S; Miller, TP; McClure, S; Fisher, RI
      Phase II trial of menogaril in non-Hodgkin's lymphomas: A Southwest Oncology Group trial

      INVESTIGATIONAL NEW DRUGS
    25. Poplin, EA; Liu, PY; Delmore, JE; Wilczynski, S; Moore, DF; Potkul, RK; Fine, BA; Hannigan, EV; Alberts, DS
      Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: A Southwest Oncology Group study

      GYNECOLOGIC ONCOLOGY
    26. Syms, RRA; Moore, DF
      Focused ion beam tuning of in-plane vibrating micromechanical resonators

      ELECTRONICS LETTERS
    27. WIERNIK PH; MOORE DF; BENNETT JM; VOGL SE; HARRIS JE; LUGER S; OKEN MM; GLICK JH
      PHASE-II STUDY OF MITOGUAZONE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE FOR PATIENTS WITH DIFFUSE HISTOLOGIC SUBTYPES OF NON-HODGKINS-LYMPHOMA - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY (PE481)

      Leukemia & lymphoma
    28. Bostock, RM; Collier, JD; Jansen, RJE; Jones, R; Moore, DF; Townsend, JE
      Silicon nitride microclips for the kinematic location of optic fibres in silicon V-shaped grooves

      JOURNAL OF MICROMECHANICS AND MICROENGINEERING
    29. DANIEL JH; IQBAL S; MILLINGTON RB; MOORE DF; LOWE CR; LESLIE DL; LEE MA; PEARCE MJ
      SILICON MICROCHAMBERS FOR DNA AMPLIFICATION

      Sensors and actuators. A, Physical
    30. MOORE DF; CABANILLAS F
      OVERVIEW OF PROGNOSTIC FACTORS IN NON-HODGKINS-LYMPHOMA

      Oncology
    31. MOORE DF; TSENOVA L; CORRAL L; FREEDMAN VH; KAPLAN G
      TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION IN HAEMOPHILUS-INFLUENZAE-B INDUCED MENINGITIS IS INHIBITED BY ALPHA-1-ACID GLYCOPROTEIN

      Annals of neurology
    32. Pazdur, R; Medgyesy, DC; Winn, RJ; Dakhil, SR; Moore, DF; Scalzo, A; Hoff, PM; Arbuck, SG; Abbruzzese, JL
      Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hour continuous infusion weekly for three weeks in metastatic colorectal carcinoma

      INVESTIGATIONAL NEW DRUGS
    33. Samlomski, WE; Lew, D; Kuebler, PJ; Kolodziej, MA; Medina, JE; Mangan, KF; Moore, DF; Schuller, DE; Ensley, JF
      Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study

      INVESTIGATIONAL NEW DRUGS
    34. MOORE DF; CURRY JI
      DETECTION AND IDENTIFICATION OF MYCOBACTERIUM-TUBERCULOSIS DIRECTLY FROM SPUTUM SEDIMENTS BY LIGASE CHAIN-REACTION

      Journal of clinical microbiology
    35. Weiss, GR; Liu, PY; Alberts, DS; Peng, YM; Fisher, E; Xu, MJ; Scudder, SA; Baker, LH; Moore, DF; Lippman, SM
      13-cis-retinoic acid or all-trans-retinoic acid plus inteferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial

      GYNECOLOGIC ONCOLOGY
    36. MOORE DF; ROSENFELD MR; ABREY LE
      SYSTEMIC RELAPSE FOLLOWING PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL)

      Neurology
    37. RITTER G; MOORE DF; CASHMAN NR; DALMAU J
      MOTOR-NEURON DISEASE-ASSOCIATED WITH MELANOMA AND ANTI-SULFATIDE ANTIBODIES

      Neurology
    38. HANLON AL; MOORE DF; HANKS GE
      MODELING POSTRADIATION PROSTATE-SPECIFIC ANTIGEN LEVEL KINETICS - PREDICTORS OF RISING POSTNADIR SLOPE SUGGEST CURE IN MEN WHO REMAIN BIOCHEMICALLY FREE OF PROSTATE CARCINOMA

      Cancer
    39. REDDY SP; HARWOOD RM; MOORE DF; GRIMM EA; MURRAY JL; VADHANRAJ S
      RECOMBINANT INTERLEUKIN-2 IN COMBINATION WITH RECOMBINANT INTERFERON-GAMMA IN PATIENTS WITH ADVANCED MALIGNANCY - A PHASE-1 STUDY

      Journal of immunotherapy with emphasis on tumor immunology
    40. MOORE DF; PAUZA AJ; BOOIJ WE; BLAMIRE MG; HERRMANN K; BAUDENBACHER F; HARNISCH T; WALKER JF; CADE N; JEDAMZIK D
      ASYMMETRIC YBACUO INTERFEROMETERS AND SQUIDS MADE WITH FOCUSED ELECTRON-BEAM IRRADIATION JUNCTIONS

      IEEE transactions on applied superconductivity
    41. BLAMIRE MG; BOOIJ WE; PAUZA AJ; TARTE EJ; MOORE DF
      IMPROVEMENTS IN THE PROPERTIES OF ELECTRON-BEAM DAMAGE YBA2CU3O7-DELTA JUNCTIONS

      IEEE transactions on applied superconductivity
    42. BOOIJ WE; PAUZA AJ; MOORE DF; TARTE EJ; BLAMIRE MG
      ELECTRODYNAMICS OF CLOSELY COUPLED YBA2CU3O7-DELTA JUNCTIONS

      IEEE transactions on applied superconductivity
    43. GROSS CW; ZACHMANN GC; BECKER DG; VICKERY CL; MOORE DF; LINDSEY WH; GROSS WE
      FOLLOW-UP OF UNIVERSITY-OF-VIRGINIA EXPERIENCE WITH THE MODIFIED LOTHROP PROCEDURE

      American journal of rhinology
    44. BURGESS SC; MOORE DF; NEWLAND DE; KLAUBERT HL
      A STUDY OF MECHANICAL CONFIGURATION OPTIMIZATION IN MICROSYSTEMS

      RESEARCH IN ENGINEERING DESIGN-THEORY APPLICATIONS AND CONCURRENT ENGINEERING
    45. HERRMANN K; PAUZA AJ; BAUDENBACHER F; SANTISO JS; MOORE DF
      ELECTROMIGRATION EFFECTS IN E-BEAM JUNCTIONS

      Physica. C, Superconductivity
    46. MACKAS DL; KIESER R; SAUNDERS M; YELLAND DR; BROWN RM; MOORE DF
      AGGREGATION OF EUPHAUSIIDS AND PACIFIC LAKE (MERLUCCIUS-PRODUCTUS) ALONG THE OUTER CONTINENTAL-SHELF OFF VANCOUVER-ISLAND

      Canadian journal of fisheries and aquatic sciences
    47. MOORE DF; ROSENFELD MR; GRIBBON PM; WINLOVE CP; TSAI CM
      ALPHA-1-ACID (AAG, OROSOMUCOID) GLYCOPROTEIN - INTERACTION WITH BACTERIAL LIPOPOLYSACCHARIDE AND PROTECTION FROM SEPSIS

      Inflammation
    48. VANBESIEN KW; DELIMA M; GIRALT SA; MOORE DF; KHOURI IF; RONDON G; MEHRA R; ANDERSSON BS; DYER C; CLEARY K; PRZEPIORKA D; GAJEWSKI JL; CHAMPLIN RE
      MANAGEMENT OF LYMPHOMA RECURRENCE AFTER ALLOGENEIC TRANSPLANTATION - THE RELEVANCE OF GRAFT-VERSUS-LYMPHOMA EFFECT

      Bone marrow transplantation
    49. DANIEL JH; MOORE DF; WALKER JF; WHITNEY JT
      FOCUSED ION-BEAMS IN MICROSYSTEM FABRICATION

      Microelectronic engineering
    50. BOOIJ WE; PAUZA AJ; TARTE EJ; MOORE DF; BLAMIRE MG
      PROXIMITY COUPLING IN HIGH-T-C JOSEPHSON-JUNCTIONS PRODUCED BY FOCUSED ELECTRON-BEAM IRRADIATION

      Physical review. B, Condensed matter
    51. SLACHTA CA; JEEVANANDAAM V; GOLDMAN B; MOORE DF; EISEN H; HECKEL M; SALGAME P; PLATSOUCAS CD
      IL-2 AND IFN-GAMMA CYTOKINE TRANSCRIPTS CORRELATE WITH GRADE OF REJECTION IN HUMAN ENDOMYOCARDIAL BIOPSIES

      Journal of allergy and clinical immunology
    52. MOORE DF; DANIEL JH; WALKER JF
      NANOTECHNOLOGY AND MICROTECHNOLOGY APPLICATIONS OF FOCUSED ION-BEAM PROCESSING

      Microelectronics
    53. PAUZA AJ; BOOIJ WE; HERRMANN K; MOORE DF; BLAMIRE MG; RUDMAN DA; VALE LR
      ELECTRON-BEAM DAMAGED HIGH-TEMPERATURE SUPERCONDUCTOR JOSEPHSON-JUNCTIONS

      Journal of applied physics
    54. SCHIFF ND; MOORE DF; WINTERKORN JMS
      PREDOMINANT DOWNGAZE OPHTHALMOPARESIS IN ANTI-HU ENCEPHALOMYELITIS

      Journal of neuro-ophthalmology
    55. WALKER JF; MOORE DF; WHITNEY JT
      FOCUSED ION-BEAM PROCESSING FOR MICROSCALE FABRICATION

      Microelectronic engineering
    56. MOORE DF; WANG EL; HULL ML
      AN EMPIRICAL-MODEL FOR DETERMINING THE RADIAL FORCE-DEFLECTION CHARACTERISTICS OF OFF-ROAD BICYCLE TIRES

      International journal of vehicle design
    57. MOORE DF; CURRY JI; KNOTT CA; JONAS V
      AMPLIFICATION OF RIBOSOMAL-RNA FOR ASSESSMENT OF TREATMENT RESPONSE OF PULMONARY TUBERCULOSIS PATIENTS DURING ANTIMICROBIAL THERAPY

      Journal of clinical microbiology
    58. PAUZA AJ; BOOIJ WE; MOORE DF; YUAN Y
      ELECTRON-BEAM DAMAGE JOSEPHSON-JUNCTIONS - THE RELATION BETWEEN BEAM DAMAGE PROFILE AND ELECTRICAL-PROPERTIES

      Czechoslovak journal of Physics
    59. MOORE DF; SCHMIDT DR; MOORE DF; KOVACH KL; WEBER HP
      SEVERE METABOLIC-ACIDOSIS ASSOCIATED WITH THE THERAPEUTIC USE OF INTERLEUKIN-2 IN NON-HODGKINS-LYMPHOMA

      Blood
    60. MOORE DF; PRETI A; TRAN SM; HAGEMEISTER FB; RODRIGUEZ MA; MCLAUGHLIN P; ROMAGUERA J; SARRIS A; YOUNES A; MOORE DF; CABANILLAS F
      PROGNOSTIC IMPLICATIONS FOLLOWING AN INDETERMINATE NONDIAGNOSTIC WORK-UP OF LYMPHOMA

      Blood
    61. DEMEO LR; DRAPER DL; MCGREGOR JA; MOORE DF; PETER CR; KAPERNICK PS; MCCORMACK WM
      EVALUATION OF A DEOXYRIBONUCLEIC-ACID PROBE FOR THE DETECTION OF TRICHOMONAS-VAGINALIS IN VAGINAL SECRETIONS

      American journal of obstetrics and gynecology
    62. HARNISCH T; UHLMANN FH; TOPFER H; MOORE DF; PAUZA AJ; LAMACRAFT K
      MODELING OF AN ADC BASED ON HIGH-T-C QOJS COMPARATORS

      IEEE transactions on applied superconductivity
    63. PAUZA AJ; MOORE DF; CAMPBELL AM; BROERS AN; CHAR K
      ELECTRON-BEAM DAMAGED HIGH-T-C JUNCTIONS - STABILITY, REPRODUCIBILITYAND SCALING LAWS

      IEEE transactions on applied superconductivity
    64. MOORE DF; GROGAN JB; LINDSEY WH; ANAND VK; GROSS CW
      THE MYOSPHERULOTIC POTENTIAL OF WATER-SOLUBLE OINTMENTS

      American journal of rhinology
    65. LINDSEY WH; HOARE JR; MOORE DF; GILES WG; GROSS CW
      ENDOSCOPIC DIAGNOSIS AND TREATMENT OF NASOLACRIMAL DUCT CYSTS CAUSINGUPPER AIRWAY-OBSTRUCTION IN THE NEONATE

      American journal of rhinology
    66. MOORE DF; MOULOPOULOS LA; DIMOPOULOS MA
      WALDENSTROM MACROGLOBULINEMIA PRESENTING AS A RENAL OR PERIRENAL MASS- CLINICAL AND RADIOGRAPHIC FEATURES

      Leukemia & lymphoma
    67. STEVENS PE; MOORE DF; HOUSE IM; VOLANS GN; RAINFORD DJ
      SIGNIFICANT ELIMINATION OF BISMUTH BY HEMODIALYSIS WITH A NEW HEAVY-METAL CHELATING AGENT

      Nephrology, dialysis, transplantation
    68. MOORE DF; PAZDUR R; SUGARMAN S; JONES D; LIPPMAN SM; BREADY B; ABBRUZZESE JL
      PILOT PHASE-II TRIAL OF 13-CIS-RETINOIC ACID AND INTERFERON-ALPHA COMBINATION THERAPY FOR ADVANCED PANCREATIC ADENOCARCINOMA

      American journal of clinical oncology
    69. VISVESVARA GS; DASILVA AJ; CROPPO GP; PIENIAZEK NJ; LEITCH GJ; FERGUSON D; DEMOURA H; WALLACE S; SLEMENDA SB; TYRRELL I; MOORE DF; MEADOR J
      IN-VITRO CULTURE AND SEROLOGIC AND MOLECULAR-IDENTIFICATION OF SEPTATA-INTESTINALIS ISOLATED FROM URINE OF A PATIENT WITH AIDS

      Journal of clinical microbiology
    70. MOORE DF; CURRY JI
      DETECTION AND IDENTIFICATION OF MYCOBACTERIUM-TUBERCULOSIS DIRECTLY FROM SPUTUM SEDIMENTS BY AMPLICOR PCR

      Journal of clinical microbiology
    71. SZARKA CE; PFEIFFER GR; HUM ST; EVERLEY LC; BALSHEM AM; MOORE DF; LITWIN S; GOOSENBERG EB; FRUCHT H; ENGSTROM PF; CLAPPER ML
      GLUTATHIONE-S-TRANSFERASE ACTIVITY AND GLUTATHIONE-S-TRANSFERASE MU-EXPRESSION IN SUBJECTS WITH RISK FOR COLORECTAL-CANCER

      Cancer research
    72. SAKKAS LI; MOORE DF; AKRITIDIS NC
      CANCER IN FAMILIES WITH SYSTEMIC-SCLEROSIS

      The American journal of the medical sciences
    73. MOORE DF; VADHANRAJ S
      SUSTAINED RESPONSE IN FELTYS-SYNDROME TO PROLONGED ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (RHGM-CSF)

      The American journal of medicine
    74. PAZDUR R; MOORE DF; BREADY B; GIANNONE L; MALDONADO A; LIN YG; FUEGER RH; WINN RJ; LEVIN B
      PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR-CARCINOMA

      Annals of oncology
    75. MOORE DF; PAZDUR R; ABBRUZZESE JL; AJANI JA; DUBOVSKY DW; WADE JL; BELT RJ; MANGOLD C; BREADY B; WINN RJ
      PHASE-II TRIAL OF EDATREXATE IN PATIENTS WITH ADVANCED PANCREATIC ADENOCARCINOMA

      Annals of oncology
    76. PAUZA AJ; CAMPBELL AM; MOORE DF; SOMEKH RE; BROERS AN
      JOSEPHSON-JUNCTIONS IN YBA2CU3O7-DELTA BY ELECTRON-BEAM IRRADIATION

      Physica. B, Condensed matter
    77. MOORE DF; BENTLEY AM; DAWLING S; HOARE AM; HENRY JA
      FOLINIC ACID AND ENHANCED RENAL ELIMINATION IN FORMIC-ACID INTOXICATION

      Journal of toxicology. Clinical toxicology
    78. GELLERT GA; MOORE DF; MAXWELL RM; MAI KK; HIGGINS KV
      TARGETED HIV SEROPREVALENCE AMONG VIETNAMESE IN SOUTHERN CALIFORNIA

      Genitourinary medicine
    79. ROMAGUERA JE; RODRIGUEZ MA; HAGEMEISTER FB; MCLAUGHLIN P; SWAN F; MOORE DF; SARRIS AH; YOUNES A; HILL D; CABANILLAS F
      A PHASE-II TRIAL OF ORAL ETOPOSIDE WITH MITOXANTRONE AND IFOSFAMIDE MESNA CONSOLIDATED WITH INTRAVENOUS ETOPOSIDE, METHYLPREDNISOLONE, HIGH-DOSE ARABINOSIDE, AND CISPLATIN AS SALVAGE THERAPY FOR RELAPSING AND OR REFRACTORY LYMPHOMAS/

      Investigational new drugs
    80. MOORE DF; PAZDUR R; ABBRUZZESE JL
      PHASE-II TRIAL OF INTRAVENOUS MELPHALAN IN ADVANCED COLORECTAL-CARCINOMA

      Investigational new drugs
    81. MOORE DF; WOOD DF; VOLANS GN
      FEATURES, PREVENTION AND MANAGEMENT OF ACUTE OVERDOSE DUE TO ANTIDIABETIC DRUGS (VOL 9, PG 218, 1993)

      Drug safety
    82. MOORE DF; OCALLAGHAN CA; BERLYNE G; OGG CS; DAVIES HA; HOUSE IM; HENRY JA
      ACUTE ARSENIC POISONING - ABSENCE OF POLYNEUROPATHY AFTER TREATMENT WITH 2,3-DIMERCAPTOPROPANESULPHONATE (DMPS)

      Journal of Neurology, Neurosurgery and Psychiatry
    83. MOORE DF; BUESCHER S; VADHANRAJ S
      INTERLEUKIN-1-ALPHA ADMINISTRATION INCREASES ORAL GRANULOCYTES AND EPITHELIAL-CELLS

      The Journal of infectious diseases
    84. DAKHIL SR; HYNES HE; CANNON MW; JOHNSON DB; MOORE DF
      G-CSF PLUS CIPROFLOXACIN IN THE PREVENTION OF SEPSIS IN PATIENTS WITHSEVERE NEUTROPENIA RELATED TO CHEMOTHERAPY

      Blood
    85. MOORE DF; HAGEMEISTER FB; RODRIGUEZ MA; ROMAGUERA JE; MCLAUGHLIN P; CABANILLAS F; FULLER L
      CLINICAL CHARACTERISTICS AND OUTCOME OF HODGKINS-DISEASE (HD) IN 125 PATIENTS (PT) 60 YEARS OF AGE AND OLDER

      Blood
    86. ROMAGUERA JE; SARRIS AH; SWAN F; YOUNES A; MCLAUGHLIN P; RODRIGUEZ MA; MOORE DF; CABANILLAS F
      PHASE-II STUDY OF 5-FLUOROURACIL BY PROTRACTED INFUSION IN PATIENTS WITH RELAPSING OR REFRACTORY LYMPHOMA

      Blood
    87. MOORE DF; MOORE DF; JOHNSON DB; CANNON MW; WHISMAN SA; CHURCH PS; PALCO W; DAKHIL S; HYNES HE
      BETHESDA UNIT TITER AS A PROGNOSTIC FACTOR FOR PATIENTS WITH ACQUIREDFACTOR-VIII INHIBITORS

      Blood
    88. MOORE DF; SEARS DA
      PICA, IRON-DEFICIENCY, AND THE MEDICAL HISTORY

      The American journal of medicine
    89. MOORE DF; LUTWYCHE MI; HOOLE ACF
      FABRICATION OF FREESTANDING STRUCTURES AND PROPOSED APPLICATIONS IN TUNNELING SENSORS

      Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena
    90. HOOLE ACF; MOORE DF; BROERS AN
      DIRECTLY PATTERNED LOW-VOLTAGE PLANAR TUNGSTEN LATERAL FIELD-EMISSIONSTRUCTURES

      Journal of vacuum science & technology. B, Microelectronics and nanometer structures processing, measurement and phenomena
    91. MOORE DF; CABANILLAS F
      WHAT CONSTITUTES A CURE IN LYMPHOMA

      Leukemia & lymphoma
    92. MOORE DF; HOOLE ACF; HEAVER A
      MICROFABRICATION OF FREESTANDING MICROSTRUCTURES

      Microelectronic engineering
    93. MOORE DF; WOOD DF; VOLANS GN
      FEATURES, PREVENTION AND MANAGEMENT OF ACUTE OVERDOSE DUE TO ANTIDIABETIC DRUGS

      Drug safety
    94. JONAS V; ALDEN MJ; CURRY JI; KAMISANGO K; KNOTT CA; LANKFORD R; WOLFE JM; MOORE DF
      DETECTION AND IDENTIFICATION OF MYCOBACTERIUM-TUBERCULOSIS DIRECTLY FROM SPUTUM SEDIMENTS BY AMPLIFICATION OF RIBOSOMAL-RNA

      Journal of clinical microbiology
    95. GELLERT G; MOORE DF; GREENWOOD R; MAXWELL RM; WEISMULLER PC
      MORE ON OFFICE-BASED TESTING FOR HIV - REPLY

      The New England journal of medicine
    96. GLEDHILL JA; MOORE DF; BELL D; HENRY JA
      SUBARACHNOID HEMORRHAGE ASSOCIATED WITH MDMA ABUSE

      Journal of Neurology, Neurosurgery and Psychiatry
    97. MOORE DF; ANDREEFF M; MAHADEVIA R; VAN N; ZHAO S; GOODACRE A; JEHA S; VADHANRAJ S
      EFFECTS OF THE FUSION PROTEIN PIXY321 ON THE PROLIFERATION OF BONE-MARROW CELLS IN PATIENTS WITH DIAMOND-BLACKFAN ANEMIA

      Blood
    98. FINKELSTEIN DM; MOORE DF; SCHOENFELD DA
      A PROPORTIONAL HAZARDS MODEL FOR TRUNCATED AIDS DATA

      Biometrics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 01:13:52